Lipschütz acute vulvar ulcer related to COVID-19 vaccination: First case report in South America

Lucero Sangster-Carrasco, Romario Paz-Temoche, Julia Coronado-Arroyo, Marcio Concepción-Zavaleta, Pela Roseboom, Luis Concepción-Urteaga, Francisca Zavaleta-Gutiérrez

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Lipschütz ulcer is a non-sexually transmitted genital lesion of unknown etiology, which pres-ents as a painful vulvar ulcer. Lipschütz ulcers have been described in most continents. This is the first case reported in Peru and South America. We present the case of a 33-year-old female patient with a Lipschütz ulcer after being vaccinated with the second dose of the AstraZeneca COVID-19 vaccine. She reported having had only one sexual partner in her lifetime. Laboratory results were negative for herpes simplex 2, Cytomegalovirus, Toxoplasma gondii, Epstein-Barr virus, and syphilis. The patient received symptomatic treatment. Ten days after the onset, the patient was significantly better during follow-up. This case report displays a potential adverse effect of the AstraZeneca COVID-19 vaccine as a Lipschütz ulcer triggered by the host humoral immune response. However, further research is needed to establish the causal relationship between these two.

Translated title of the contributionÚlcera vulvar aguda de Lipschütz relacionada con la vacunación por COVID-19: primer caso notificado en Sudamérica
Original languageEnglish
Article numbere2674
JournalMedwave
Volume23
Issue number2
DOIs
StatePublished - Mar 2023
Externally publishedYes

Keywords

  • COVID-19
  • COVID-19 Vaccine
  • ChAdOx1 nCoV-19
  • Coronavirus Disease 2019
  • Vulvar ulcer

Fingerprint

Dive into the research topics of 'Lipschütz acute vulvar ulcer related to COVID-19 vaccination: First case report in South America'. Together they form a unique fingerprint.

Cite this